Pocket Prescriber Psychiatry
Herausgeber: Rogers, Jonathan; Nicholson, Timothy Rj; Butler, Matt
Pocket Prescriber Psychiatry
Herausgeber: Rogers, Jonathan; Nicholson, Timothy Rj; Butler, Matt
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Pocket Prescriber Psychiatry, 2E is an up-to-date prescribing guide containing all the information that psychiatrists and mental health professionals.This book provides the key essential information for all mental health professionals prescribing drugs and is endorsed by the British Association for Psychopharmacology.
Andere Kunden interessierten sich auch für
- Timothy RJ NicholsonPocket Prescriber 201535,99 €
- Christopher Doran MD (US University of Colorado School of MedicinePrescribing Mental Health Medication73,99 €
- Chris HartA Pocket Guide to Risk Assessment and Management in Mental Health48,99 €
- Chris HartA Pocket Guide to Risk Assessment and Management in Mental Health48,99 €
- Patricia Casey (University College Dublin)Fish's Clinical Psychopathology38,99 €
- Craig Batista (Imperial College and Cl The Royal Brompton HospitalPocket Prescriber Pulmonary Medicine26,99 €
- Sheila Barrett / Carol Komaromy / Martin Robb / Anita Rogers (eds.)Communication, Relationships and Care59,99 €
-
-
-
Pocket Prescriber Psychiatry, 2E is an up-to-date prescribing guide containing all the information that psychiatrists and mental health professionals.This book provides the key essential information for all mental health professionals prescribing drugs and is endorsed by the British Association for Psychopharmacology.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Pocket Prescriber Series
- Verlag: Taylor & Francis Ltd
- 2 ed
- Seitenzahl: 496
- Erscheinungstermin: 20. Juni 2024
- Englisch
- Abmessung: 105mm x 145mm x 26mm
- Gewicht: 440g
- ISBN-13: 9781032397412
- ISBN-10: 1032397411
- Artikelnr.: 69793127
- Pocket Prescriber Series
- Verlag: Taylor & Francis Ltd
- 2 ed
- Seitenzahl: 496
- Erscheinungstermin: 20. Juni 2024
- Englisch
- Abmessung: 105mm x 145mm x 26mm
- Gewicht: 440g
- ISBN-13: 9781032397412
- ISBN-10: 1032397411
- Artikelnr.: 69793127
Matt Butler MRes MRCPsych Wellcome Trust Doctoral Clinical Research Fellow, Institute of Psychiatry, Psychology and Neuroscience and Specialist Registrar in Psychiatry, King's College London and South London and Maudsley NHS Foundation Trust Timothy RJ Nicholson MBBS BSc MSc PhD MRCP MRCPsych Reader in Neuropsychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London and Honorary Consultant Neuropsychiatrist, South London & Maudsley NHS Foundation Trust, London, UK Jonathan P Rogers MA MB BChir MRCP MRCPsych NIHR Clinical Lecturer, Division of Psychiatry, University College London, UK
Common/useful drugs. Disorders. Psychosis. Bipolar affective disorder.
Depression. Anxiety disorders. Dementia. Attention deficit hyperactivity
disorder (ADHD). Sleep disorders and agitation. Substance misuse.
Non-pharmacological treatments. Psychoeducation. Crisis planning. Lifestyle
interventions. Social interventions. Psychological therapies.
Neurostimulation. Psychosurgery. Basic psychopharmacology.
Pharmacokinetics. Pharmacodynamics. Neurotransmitter systems. Drug
interactions. Miscellaneous. Prescribing in the perinatal period.
Prescribing in autism. Prescribing in personality disorders. Controlled
drugs (CDs). Off-license prescribing. Psychiatric side effects of
medications. Medication adherence. Risk assessment. Psychiatric
classification. Mental Health Act (MHA) in England and Wales. Mental
Capacity Act (MCA) in England and Wales. Emergencies. Rapid tranquilisation
(RT). Drug toxicity syndromes. Alcohol and drug withdrawal syndromes.
Catatonia. Delirium. Seizures (epileptic and dissociative). Acute dystonia.
Clozapine-induced agranulocytosis. HIV post-exposure prophylaxis (PEP).
Hanging. Self-laceration. Acute coronary syndromes (ACS). Acute asthma.
Chronic obstructive pulmonary disease exacerbation. Pulmonary embolism.
Sepsis (severe or septic shock). Diabetic ketoacidosis (DKA). ¿Glucose.
Reference information. Guidelines. Useful contacts. Reference values.
Index.
Depression. Anxiety disorders. Dementia. Attention deficit hyperactivity
disorder (ADHD). Sleep disorders and agitation. Substance misuse.
Non-pharmacological treatments. Psychoeducation. Crisis planning. Lifestyle
interventions. Social interventions. Psychological therapies.
Neurostimulation. Psychosurgery. Basic psychopharmacology.
Pharmacokinetics. Pharmacodynamics. Neurotransmitter systems. Drug
interactions. Miscellaneous. Prescribing in the perinatal period.
Prescribing in autism. Prescribing in personality disorders. Controlled
drugs (CDs). Off-license prescribing. Psychiatric side effects of
medications. Medication adherence. Risk assessment. Psychiatric
classification. Mental Health Act (MHA) in England and Wales. Mental
Capacity Act (MCA) in England and Wales. Emergencies. Rapid tranquilisation
(RT). Drug toxicity syndromes. Alcohol and drug withdrawal syndromes.
Catatonia. Delirium. Seizures (epileptic and dissociative). Acute dystonia.
Clozapine-induced agranulocytosis. HIV post-exposure prophylaxis (PEP).
Hanging. Self-laceration. Acute coronary syndromes (ACS). Acute asthma.
Chronic obstructive pulmonary disease exacerbation. Pulmonary embolism.
Sepsis (severe or septic shock). Diabetic ketoacidosis (DKA). ¿Glucose.
Reference information. Guidelines. Useful contacts. Reference values.
Index.
Common/useful drugs. Disorders. Psychosis. Bipolar affective disorder.
Depression. Anxiety disorders. Dementia. Attention deficit hyperactivity
disorder (ADHD). Sleep disorders and agitation. Substance misuse.
Non-pharmacological treatments. Psychoeducation. Crisis planning. Lifestyle
interventions. Social interventions. Psychological therapies.
Neurostimulation. Psychosurgery. Basic psychopharmacology.
Pharmacokinetics. Pharmacodynamics. Neurotransmitter systems. Drug
interactions. Miscellaneous. Prescribing in the perinatal period.
Prescribing in autism. Prescribing in personality disorders. Controlled
drugs (CDs). Off-license prescribing. Psychiatric side effects of
medications. Medication adherence. Risk assessment. Psychiatric
classification. Mental Health Act (MHA) in England and Wales. Mental
Capacity Act (MCA) in England and Wales. Emergencies. Rapid tranquilisation
(RT). Drug toxicity syndromes. Alcohol and drug withdrawal syndromes.
Catatonia. Delirium. Seizures (epileptic and dissociative). Acute dystonia.
Clozapine-induced agranulocytosis. HIV post-exposure prophylaxis (PEP).
Hanging. Self-laceration. Acute coronary syndromes (ACS). Acute asthma.
Chronic obstructive pulmonary disease exacerbation. Pulmonary embolism.
Sepsis (severe or septic shock). Diabetic ketoacidosis (DKA). ¿Glucose.
Reference information. Guidelines. Useful contacts. Reference values.
Index.
Depression. Anxiety disorders. Dementia. Attention deficit hyperactivity
disorder (ADHD). Sleep disorders and agitation. Substance misuse.
Non-pharmacological treatments. Psychoeducation. Crisis planning. Lifestyle
interventions. Social interventions. Psychological therapies.
Neurostimulation. Psychosurgery. Basic psychopharmacology.
Pharmacokinetics. Pharmacodynamics. Neurotransmitter systems. Drug
interactions. Miscellaneous. Prescribing in the perinatal period.
Prescribing in autism. Prescribing in personality disorders. Controlled
drugs (CDs). Off-license prescribing. Psychiatric side effects of
medications. Medication adherence. Risk assessment. Psychiatric
classification. Mental Health Act (MHA) in England and Wales. Mental
Capacity Act (MCA) in England and Wales. Emergencies. Rapid tranquilisation
(RT). Drug toxicity syndromes. Alcohol and drug withdrawal syndromes.
Catatonia. Delirium. Seizures (epileptic and dissociative). Acute dystonia.
Clozapine-induced agranulocytosis. HIV post-exposure prophylaxis (PEP).
Hanging. Self-laceration. Acute coronary syndromes (ACS). Acute asthma.
Chronic obstructive pulmonary disease exacerbation. Pulmonary embolism.
Sepsis (severe or septic shock). Diabetic ketoacidosis (DKA). ¿Glucose.
Reference information. Guidelines. Useful contacts. Reference values.
Index.